28 Dec $4.7 Billion Talc Verdict against Johnson and Johnson Upheld by Trial Court
As first reported in Law360, St. Louis Circuit Court Judge Rex Burlison upheld the jury’s $4.7 billion verdict against Johnson and Johnson. The Judge noted “First, substantial evidence was adduced at trial of particularly reprehensible conduct on the part of defendants, including that defendants knew of the presence of asbestos in products that they knowingly targeted for sale to mothers and babies, knew of the damage their products caused and misrepresented the safety of these products for decades,” the judge said. “Second, defendants’ actions caused significant physical harm and potential harm, includingovarian cancer in plaintiffs or plaintiffs’ decedents.”
The Judge denied J&J’s request for a new and separate trial and denied the challenge of the expert testimony at trial noting “The evidence presented at trial includes the testimony of plaintiffs’ expert witnesses, evidence of the testing of the products at issue, including defendants’ own testing, defendants’ correspondence and the testimony of defendants’ own corporate representative and chief medical officer,” as stated by Judge Burlison
The case is Ingham v. Johnson & Johnson et al., case number 1522-CC10417, in the 22nd Judicial Circuit of Missouri.